Author: Guay, David RP

Source: Aging Health, Volume 2, Number 4, August 2006 , pp. 669-690(22)

Publisher: Future Medicine

Abstract:

Naturally occurring opioids have been used as analgesics for thousands of years. From these, semisynthetic and synthetic derivatives have emerged in the search for the `perfect' opioid analgesic, without success. Weak opioid analgesics include codeine and propoxyphene, intermediate-strength opioid analgesics include the agonist-antagonists (e.g., pentazocine and butorphanol) and the partial agonist buprenorphine and the strong opioid analgesics include morphine, oxycodone, oxymorphone, hydrocodone, hydromorphone, fentanyl and meperidine. Propoxyphene, meperidine, agonist-antagonists and partial agonists should be avoided in most elderly patients owing to their unfavorable risk-benefit profiles. The other opioids can be recommended for use in the elderly and appear to be interchangeable (in equianalgesic doses) based upon similar efficacy and tolerability profiles. The aging process alters the pharmacokinetics of nearly all opioid analgesics, mainly due to alternations in the activity of excretory pathways (liver and kidneys). The need for frequent dosing of these drugs, due to their short terminal disposition half-lives, can be largely overcome by using oral or transdermal extended-release formulations that allow dosing as infrequently as every 3 days. Opioid side effects can be anticipated and, in virtually all cases, either tolerance develops or pre-emptive therapy can prevent the emergence of or minimize the impact of the side effect (e.g., laxative therapy prevents constipation). Opioid analgesics are effective for virtually all types of pain, including neuropathic pain (where chronic opioid therapy works, while `as-needed' therapy does not). This review summarizes the evidence for and against the use of individual opioid analgesics in the elderly. This, in turn, should promote the safe and effective use of the preferred opioid analgesics in this patient population.

Keywords: codeine; fentanyl; hydrocodone; hydromorphone; meperidine; morphine; opioids; oxycodone; oxymorphone; pain; propoxyphene

Document Type: Research article

DOI: http://dx.doi.org/10.2217/1745509X.2.4.669

Affiliations: 1: University of Minnesota, College of Pharmacy, Weaver-Densford Hall 7-115C, 308 Harvard Street SE, Minneapolis, MN 55455, USA., Email: guayx001@umn.edu

Publication date: 2006-08-01

More about this publication?

• Aging Health leading coverage of current and emerging topics relating to the safe and effective management of therapy in the elderly, all subject to rigorous peer review. The journal focuses on the most important advances and highlights their relevance in the clinical setting. The journal has been designed to deliver essential concise information in an easily assimilable format - vital for the increasingly time-constrained professional.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• E-Access Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Medicine (General) ,  Nursing
• By this author: Guay, David RP

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers